Type
Outsourcing
Country
France
Region
île de France; Hauts-de-Seine;
Location of affected unit(s)
Rueil-Malmaison
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture of pharmaceutical preparations

122 jobs
Number of planned job losses
Job loss
Announcement Date
17 October 2015
Employment effect (start)
2 November 2015
Foreseen end date

Description

The US pharmaceutical group Bristol-Myers Squibb (BMS) announced that 122 workers will be made redundant in the headquarter of its subsidiary UPSA, at Rueil-Malmaison. Most of the cuts are due to the externalization of the customer service function from UPSA to an outside company.

The job cuts will mainly affect its administrative, support and commercial workforce. The BMS group previously cut 235 positions in 2013 (see previous factsheet).


Sources

  • 17 October 2015: La dépêche du midi
  • 22 October 2015: Le Petit Bleu

Citation

Eurofound (2015), UPSA, Outsourcing in France, factsheet number 85149, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/85149.